Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?

Wang, Na; Wang, Xinxin; Li, Wenya; Ye, Huajun; Bai, Hongzhao; Wu, Jiansheng; Chen, Mengjun

Wang, Na; Wang, Xinxin; Li, Wenya; Ye, Huajun; Bai, Hongzhao; Wu, Jiansheng; Chen, Mengjun.

Afiliación

Wang N; Health Care Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Wang X; Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Li W; Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Ye H; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Bai H; Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Wu J; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.
Chen M; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325002, People's Republic of China.

Cancer Manag Res ; 12: 1211-1219, 2020.

Article en En | MEDLINE | ID: mdl-32110095

Palabras clave

contrast-enhanced-CT; gastric adenocarcinoma; human epidermal growth factor receptor 2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google